| Name | Title | Contact Details |
|---|
Powerful platform that connects brands and agencies with vetted and trustworthy influencers for the purposes of: Link Building, Content Marketing, and Social Media Campaigns.
Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.
Cavium (NASDAQ: CAVM) is a provider of highly integrated semiconductor processors that enable intelligent networking, communications, storage, video and security applications. Cavium offers a broad portfolio of integrated, software compatible processo...
Ride Report empowers cities with tools to help them make transportation more equitable, efficient and sustainable.
Harmony Healthcare IT delivers strategic planning, tactical execution and day-to-day support for safeguarding patient data and ensuring cash flow.